Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID
Objectives Methotrexate (MTX) is one of the most commonly used medications to treat rheumatoid arthritis (RA). However, the effect of MTX treatment on cellular immune responses remains incompletely understood. This raises concerns about the vulnerability of these patients to emerging infections and...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2024-10-01
|
| Serier: | RMD Open |
| Online adgang: | https://rmdopen.bmj.com/content/10/4/e004664.full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
